Cargando…

The in vitro addition of idarucizumab to plasma samples from patients increases thrombin generation

Dabigatran interferes with many coagulation tests. To overcome this obstacle the use of idarucizumab as an in vitro antidote to dabigatran has been proposed. The aim of this study was to test the effect of idarucizumab as an in vitro antidote to dabigatran in ex vivo plasma samples from routine clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Božič Mijovski, Mojca, Malmström, Rickard E., Vene, Nina, Antovic, Jovan P., Mavri, Alenka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961037/
https://www.ncbi.nlm.nih.gov/pubmed/33723299
http://dx.doi.org/10.1038/s41598-021-85318-y